Detalhe da pesquisa
1.
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
Proc Natl Acad Sci U S A
; 121(4): e2308942121, 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38241441
2.
Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model.
PLoS Pathog
; 19(11): e1011825, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38011264
3.
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.
PLoS Pathog
; 19(4): e1011298, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37075079
4.
T-SPOT.TB Reactivity in Southern African Children With and Without in Utero Human Immunodeficiency Virus Exposure.
Clin Infect Dis
; 77(8): 1133-1136, 2023 10 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37293702
5.
Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803.
J Virol
; 96(23): e0142422, 2022 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36377872
6.
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
PLoS Pathog
; 17(7): e1009278, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34228762
7.
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses.
PLoS Pathog
; 17(3): e1009386, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33651828
8.
Addendum: Immune clearance of highly pathogenic SIV infection.
Nature
; 547(7661): 123-124, 2017 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28636599
9.
RV144 HIV-1 vaccination impacts post-infection antibody responses.
PLoS Pathog
; 16(12): e1009101, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33290394
10.
In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.
PLoS Pathog
; 16(11): e1008666, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33232376
11.
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.
PLoS Pathog
; 16(2): e1008179, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32027734
12.
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.
Proc Natl Acad Sci U S A
; 115(36): E8378-E8387, 2018 09 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30127007
13.
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features.
PLoS Comput Biol
; 15(4): e1006952, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30933973
14.
Immune clearance of highly pathogenic SIV infection.
Nature
; 502(7469): 100-4, 2013 Oct 03.
Artigo
Inglês
| MEDLINE | ID: mdl-24025770
15.
Feeding-Related Gut Microbial Composition Associates With Peripheral T-Cell Activation and Mucosal Gene Expression in African Infants.
Clin Infect Dis
; 67(8): 1237-1246, 2018 09 28.
Artigo
Inglês
| MEDLINE | ID: mdl-29659737
16.
SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials.
Bioinformatics
; 33(15): 2386-2388, 2017 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28379332
17.
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.
Nature
; 490(7420): 417-20, 2012 Oct 18.
Artigo
Inglês
| MEDLINE | ID: mdl-22960785
18.
No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.
J Infect Dis
; 214(2): 258-64, 2016 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27056950
19.
Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.
PLoS Comput Biol
; 11(2): e1003973, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25646817
20.
Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.
J Virol
; 88(5): 2489-507, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24352443